These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3145323)

  • 1. Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects.
    Turkish S; Yu PH; Greenshaw AJ
    J Neural Transm; 1988; 74(3):141-8. PubMed ID: 3145323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
    Youdim MB; Tipton KF
    Parkinsonism Relat Disord; 2002 Mar; 8(4):247-53. PubMed ID: 12039419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of MAO-B enzyme activity after (-)deprenyl (selegiline) pretreatment, measured in vivo.
    Timár J
    Acta Physiol Hung; 1989; 74(3-4):259-66. PubMed ID: 2517980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
    Robinson JB
    Biochem Pharmacol; 1985 Dec; 34(23):4105-8. PubMed ID: 3933519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
    Fozard JR; Zreika M; Robin M; Palfreyman MG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):186-93. PubMed ID: 3937059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoamine oxidase-B inhibitor, MD 780236, metabolized essentially by the A form of the enzyme in the rat.
    Strolin Benedetti M; Dow J
    J Pharm Pharmacol; 1983 Apr; 35(4):238-45. PubMed ID: 6133934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
    Timár J; Knoll B
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):50-60. PubMed ID: 3083795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236.
    Kinemuchi H; Morikawa F; Ueda T; Arai Y
    Jpn J Pharmacol; 1986 Jun; 41(2):183-9. PubMed ID: 3747265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal influences on the inhibition of monoamine oxidase type B activity.
    Vaccari A; Biassoni R
    J Neurosci Res; 1982; 8(1):13-9. PubMed ID: 6816948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?
    Lewinsohn R; Glover V; Sandler M
    Biochem Pharmacol; 1980 Mar; 29(5):777-81. PubMed ID: 20227955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of 2-phenylethylamine binding after monoamine oxidase inhibition in rat brain.
    Li XM; Juorio AV; Paterson IA; Boulton AA
    Eur J Pharmacol; 1992 Jan; 210(2):189-93. PubMed ID: 1601056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation.
    Oreland L; Arai Y; Stenström A
    Acta Neurol Scand Suppl; 1983; 95():81-5. PubMed ID: 6428149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.